Dysphagia in Parkinsons disease: A therapeutic challenge?

Expert Review of Neurotherapeutics

Volumn 10, Issue 6, 2010, Pages 875-878

  Michou, Emilia ^a   Hamdy, Shaheen ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Dysphagia; Neurodegenerative disease; Parkinson's disease; Swallowing disorders

Indexed keywords

ASPIRATION PNEUMONIA; CAUSE OF DEATH; CLINICAL PRACTICE; DISEASE COURSE; DYSPHAGIA; HUMAN; INCIDENCE; MORTALITY; PARKINSON DISEASE; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SWALLOWING;

DEGLUTITION DISORDERS; DISEASE PROGRESSION; HUMANS; PARKINSON DISEASE;

EID: 77953211257     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.60     Document Type: Review

References (38)

1. Korrell M, Tanner C. Epidemiology of Parkinson's disease: an overview. In: Parkinson's Disease. Ebadi M, Pfeiffer RF (Eds). CRC Press, FL, USA 39-50 (2005).
2. Clarke CE, Gullaksen E, Macdonald S, Lowe F. Referral criteria for speech and language therapy assessment of dysphagia caused by idiopathic Parkinson's disease. Acta Neurol. Scand. 97(1), 27-35 (1998).
3. Coates C, Bakheit AMO. Dysphagia in Parkinson's disease. Eur. Neurol. 38(1), 49-52 (1997).
4. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23(6), 837-844 (2008).
5. Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-l-dopa-responsive problems dominate at 15 years. Mov. Disord. 20(2), 190-199 (2005).
6. Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol. Scand. 103(1), 7-11 (2001).
7. Leow L, Huckabee M-L, Anderson T, Beckert L. The impact of dysphagia on quality of life in ageing and Parkinson's disease as measured by the swallowing quality of life (SWAL-QOL) questionnaire. Dysphagia DOI: 10.1007/5.00455.009- 9245-9 (2009) (Epub ahead of print).
8. Plowman-Prine EK, Sapienza CM, Okun MS et al. The relationship between quality of life and swallowing in Parkinson's disease. Mov. Disord. 24(9), 1352-1358 (2009).
9. Lorefält B, Granérus A, Unosson M. Avoidance of solid food in weight losing older patients with Parkinson's disease. J. Clin. Nurs. 15(11), 1404-1412 (2006).
10. Nagaya M, Kachi T, Yamada T. Effect of swallowing training on swallowing disorders in Parkinson's disease. Scand. J. Rehabil. Med. 32(1), 11-15 (2000).
11. Ertekin C, Tarlaci S, Aydogdu I et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease. Mov. Disord. 17(5), 942-949 (2002).
12. Muller J, Wenning GK, Verny M et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch. Neurol. 58(2), 259-264 (2001).
13. Potulska A, Friedman A, Krolicki L, Spychala A. Swallowing disorders in Parkinson's disease. Parkinsonism Relat. Disord. 9(6), 349-353 (2003).
14. Miller N, Allcock L, Hildreth AJ et al. Swallowing problems in Parkinson disease: frequency and clinical correlates. J. Neurol. Neurosurg. Psychiatry 80(9), 1047-1049 (2009).
15. Paolo B, Angelo A, Carlo C et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov. Disord. 24(11), 1641-1649 (2009).
16. Baijens LWJ, Speyer R. Effects of therapy for dysphagia in Parkinson's disease: systematic review. Dysphagia 24(1), 91-102 (2009).
17. Deane KH, Whurr R, Clarke CE, Playford ED, Ben-Shlomo Y. Non-pharmacological therapies for dysphagia in Parkinson's disease. Cochrane Database Syst. Rev. 1, CD002816 (2001).
18. Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 39(10), 1309-1314 (1989).
19. Hunter PC, Crameri J, Austin S, Woodward MC, Hughes AJ. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J. Neurol. Neurosurg. Psychiatry 63(5), 579-583 (1997).
20. Lim A, Leow L, Huckabee ML, Frampton C, Anderson T. A pilot study of respiration and swallowing integration in Parkinson's disease: "On" and "Off " levodopa. Dysphagia 23(1), 76-81 (2008).
21. Bartels AL, Leenders KL. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex 45(8), 915-921 (2009).
22. Picconi B, Centonze D, Hakansson K et al. Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat. Neurosci. 6(5), 501-506 (2003).
23. Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat. Rev. Neurosci. 2(8), 577-588 (2001).
24. Clarke CE. Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. Lancet Neurol. 3(8), 466-474 (2004).
25. Poewe W, Mahlknecht P. The clinical progression of Parkinson's disease. Parkinsonism Relat. Disord. 15(Suppl. 4), S28-S32 (2009).
26. Ho AK, Bradshaw JL, Iansek R. For better or worse: the effect of levodopa on speech in Parkinson's disease. Mov. Disord. 23(4), 574-580 (2008).
27. Shill H, Stacy M. Respiratory function in Parkinson's disease. Clin. Neurosci. 5(2), 131-135 (1998).
28. Brown LK. Respiratory dysfunction in Parkinson disease. Clin. Chest Med. 15(4), 715-727 (1994).
29. Gross RD, Atwood CW, Ross SB et al. The coordination of breathing and swallowing in Parkinson's disease. Dysphagia 23(2), 136-145 (2008).
30. Pal PK, Sathyaprabha TN, Tuhina P, Thennarasu K. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa. Mov. Disord. 22(3), 420-424 (2007).
31. Debruin PF, Debruin VM, Lees AJ, Pride NB. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease. Am. Rev. Respir. Dis. 148(6), 1576-1580 (1993).
32. Troche M, Sapienza C, Rosenbek J. Effects of bolus consistency on timing and safety of swallow in patients with Parkinson's disease. Dysphagia 23(1), 26-32 (2008).
33. Russell JA, Ciucci MR, Connor NP, Schallert T. Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Res. DOI: 10.1016/j.brainres.2010.03.029 (2010) (Epub ahead of print).
34. Pitts T, Bolser D, Rosenbek J et al. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest 135(5), 1301-1308 (2009).
35. Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N. Engl. J. Med. 346(15), 1174-1175 (2002).
36. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 45(6), 1375-1382; discussion 1382-1384 (1999).
37. Ciucci MR, Barkmeier-Kraemer JM, Sherman SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease. Mov. Disord. 23(5), 676-683 (2008).
38. Manor Y, Balas M, Giladi N, Mootanah R, Cohen JT. Anxiety, depression and swallowing disorders in patients with Parkinson's disease. Parkinsonism Relat. Disord. 15(6), 453-456 (2009).